Spectral domain optical coherence tomography evaluation of macular changes in Eales disease

被引:8
作者
Goel, Neha [1 ]
Kumar, Vinod [2 ]
Arora, Supriya [3 ]
Jain, Pooja [3 ]
Ghosh, Basudeb [3 ]
机构
[1] ICARE Eye Hosp & Postgrad Inst, Noida, Uttar Pradesh, India
[2] All India Inst Med Sci, Dr RP Ctr Ophthalm Sci, New Delhi, India
[3] Maulana Azad Med Coll, Guru Nanak Eye Ctr, New Delhi, India
关键词
Eales disease; epiretinal membrane; macula; macular edema; retinal vasculitis; spectral domain optical coherence tomography; PREMACULAR SUBHYALOID HEMORRHAGE; DOUBLE-RING SIGN; NDYAG LASER; MANAGEMENT;
D O I
10.4103/ijo.IJO_845_17
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: The purpose of the study was to describe macular changes in treatment-naive eyes with Eales disease using spectral domain optical coherence tomography (SD-OCT). Methods: A cross-sectional study was done on 79 eyes of 66 patients with Eales disease. Best-corrected visual acuity (BCVA), slit-lamp biomicroscopy (SLB), indirect ophthalmoscopy, fundus fluorescein angiography (FFA), and quantitative (central macular thickness [CMT]) and qualitative analysis on SD-OCT were performed. Results: Forty-six (58.2%) eyes had macular involvement as assessed with SD-OCT, while in 33 (41.8%) eyes, macula was not affected. Macular edema was the most common feature when macula was affected followed by epiretinal membrane. Mean CMT was higher (315.3 +/- 102.3 mu m) in eyes with macular involvement than those without it (243.8 +/- 19.3 mu m). Eyes with active vasculitis involving larger vessels and neovascularization had greater chance of macular involvement. SLB and FFA alone missed 28.3% and 50% eyes with macular abnormalities on SD-OCT, respectively. Conclusion: While the clinical description of Eales disease points mainly to a peripheral location, macular involvement can be commonly picked up when SD-OCT is used. Macular involvement when present is associated with a poorer BCVA.
引用
收藏
页码:433 / 438
页数:6
相关论文
共 21 条
[1]   Intravitreal triamcinolone acetonide in Eales disease [J].
Agrawal, Shishir ;
Agrawal, Jaya ;
Agrawal, Trilok Prakash .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (02) :227-229
[2]  
Badrinath SS, 1982, ACTA INT C OPHTHALMO, V24, P536
[3]   Eales disease - An update [J].
Biswas, J ;
Sharma, T ;
Gopal, L ;
Madhavan, HN ;
Sulochana, KN ;
Ramakrishnan, S .
SURVEY OF OPHTHALMOLOGY, 2002, 47 (03) :197-214
[4]   Eales' disease - current concepts in diagnosis and management [J].
Biswas J. ;
Ravi R.K. ;
Naryanasamy A. ;
Kulandai L.T. ;
Madhavan H.N. .
Journal of Ophthalmic Inflammation and Infection, 3 (1) :1-5
[5]   Premacular subhyaloid haemorrhage in Eales' disease managed with Nd:YAG laser [J].
Chanana, B. ;
Azad, R. V. .
EYE, 2009, 23 (07) :1609-1611
[6]   Eales' disease: diagnosis and management [J].
Das, T. ;
Pathengay, A. ;
Hussain, N. ;
Biswas, J. .
EYE, 2010, 24 (03) :472-482
[7]  
Das Taraprasad, 1994, Indian Journal of Ophthalmology, V42, P3
[8]  
Goel N., 2016, RETIN CASES BRIEF RE
[9]   Nd:YAG laser hyaloidotomy in the management of Premacular Subhyaloid Hemorrhage [J].
Khadka, Deepak ;
Bhandari, Sanjeeb ;
Bajimaya, Sanyam ;
Thapa, Raba ;
Paudyal, Govinda ;
Pradhan, Eli .
BMC OPHTHALMOLOGY, 2016, 16
[10]   A comparative study of epiretinal membranes associated with Eales' disease: a clinicopathologic evaluation [J].
Majji, AB ;
Vemuganti, GK ;
Shah, VA ;
Singh, S ;
Das, T ;
Jalali, S .
EYE, 2006, 20 (01) :46-54